CONTACT US | Follow
Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
     

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVBBHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $493.6M
    • Shares Outstanding

      5,646,503
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/24/14

  • Portfolio Composition (%)
    as of 04/24/14

    • % of Net Assets

    • Stocks

      100.00
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.00
    • Total

      100.00
  • Download All Holdings All Holdings (%) as of 04/24/14

    Total Holdings: 26
    Holding Name
    Ticker
    Shares Market Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    869,506
    64,413,004 13.05
    Amgen Inc
    AMGN US
    477,482
    54,299,253 11.00
    Biogen Idec Inc
    BIIB US
    149,503
    44,079,465 8.93
    Celgene Corp
    CELG US
    301,055
    42,511,977 8.61
    Alkermes Plc
    ALKS US
    548,466
    25,383,006 5.14
    Alexion Pharmaceuticals Inc
    ALXN US
    159,788
    24,928,526 5.05
    Regeneron Pharmaceuticals Inc
    REGN US
    83,875
    24,611,441 4.99
    Illumina Inc
    ILMN US
    151,276
    22,945,544 4.65
    Vertex Pharmaceuticals Inc
    VRTX US
    320,846
    21,233,588 4.30
    Biomarin Pharmaceutical Inc
    BMRN US
    309,450
    18,347,291 3.72
    Qiagen Nv
    QGEN US
    840,120
    17,726,532 3.59
    Incyte Corp Ltd
    INCY US
    358,034
    16,935,008 3.43
    Isis Pharmaceuticals Inc
    ISIS US
    446,988
    15,733,978 3.19
    Pharmacyclics Inc
    PCYC US
    136,839
    12,928,549 2.62
    Covance Inc
    CVD US
    125,212
    11,972,771 2.43
    Cubist Pharmaceuticals Inc
    CBST US
    173,184
    11,518,468 2.33
    United Therapeutics Corp
    UTHR US
    122,681
    11,470,674 2.32
    Medivation Inc
    MDVN US
    197,248
    11,385,155 2.31
    Charles River Laboratories Internationa
    CRL US
    137,754
    7,923,610 1.61
    Intercept Pharmaceuticals Inc
    ICPT US
    25,963
    7,029,482 1.42
    Myriad Genetics Inc
    MYGN US
    149,304
    5,984,104 1.21
    Cepheid Inc
    CPHD US
    134,117
    5,840,795 1.18
    Nps Pharmaceuticals Inc
    NPSP US
    209,035
    5,351,296 1.08
    Seattle Genetics Inc
    SGEN US
    116,906
    4,597,913 0.93
    Ariad Pharmaceuticals Inc
    ARIA US
    595,795
    4,438,673 0.90
    Other/Cash
    3,949 0.00
    Total (%) 99.99
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.